SAL0140

· Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAL0140, covering 2025-07-04 to 2025-07-04. Get the full timeline:

Most recent: Clinical Trial Update: SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population [Phase 1]